CSA Annual Meeting
The CSA Annual Meeting, hosted by CSA and undertaken by Reed Sinopharm Exhibitions, is held every September in Shanghai.
CSA is China's only Level AAAAA dental association in China, enjoying the highest academic authority, influence and appeal in China.
In 2017, CSA altogether held 506 academic seminar sessions, operation & demonstration shows and prize competitions. 436 leading international and domestic experts and 27,000 representatives attended its Annual Meeting.
The Conference is also in cooperation with renowned dental institutes such as FDI Education Committee - Continuing Education Program of Asia-Pacific Region.
In 2017, CSA held the Implantology International Meeting at NECC, attracting 1200 attendees. In 2018, CSA is going to hold the Orthodontic Conference, which will attract 3500 people worldwide.
- Shared Oral Equipment
- Oral Imaging Equipment
- Oral Rehabilitation Equipment
- Oral Medical Equipment
- Oral Prevention and Healthcare Products
- Oral Orthodontic Equipment
- Oral Surgery Equipment
- Oral Implant Equipment
- Technician Equipment
- Oral Software
- Dental Hospitals
- Dental Clinics
- Dental Lab
- Dental Product Agents/Distributors/Merchants
- Dental Equipment Manufactory
- Dental Consumable Manufactory
- University/Academic Institution
Latest Developments at CDS
It is no surprise that CDS is witnessing exponentially growing demands for exhibition space, evinced by the choice of the new and upgraded venue – National Exhibition and Convention Centre (NEEC) Shanghai. This venue hosted the latest successful edition of The Health Industry Summit in May. NECC, Shanghai is equipped with all the latest hi-tech amenities to facilitate a global show such as CDS . The venue is also planned in the most ergonomic fashion, allowing exhibitors and visitors within the same product portfolio to interact on the same floor, thus obtaining great results within limited time.
CDS has responded to the growing demand for space by acquiring one entire hall to provide comfortable exhibition spaces and meeting rooms. Mr Wei Qinghua, Project Manager at RSE, explains, “We have seen exhibition space requests coming in not only from individual companies but also from national pavilion, a clear indicator that CDS is gaining its international reputation. With less than five months to go for CDS, the international section has already increased by over 30%, as compared to last year. We look forward to introducing new products and strengthening the product portfolio from each specific country at this edition.” CDS will see another 2-3 countries pavilions in addition to the ones who have been participating regularly.”
Currently, CDS is witnessing highest interest not only from exhibitors but also from visitors who are looking for quality products from China at competitive prices. Thus, with the excitement and anticipation building up towards CDS, all you have to do is pre-register yourself now!
Reed Sinopharm Exhibitions CO., LTD. (Reed Sinopharm)
Reed Sinopharm Exhibitions CO., LTD. (Reed Sinopharm) is one of the most renowned event organizers dedicated to pharmaceutical and medical sectors in China. The company is a joint venture between China National Pharmaceutical Group Corporation (Sinopharm) – the largest medical and healthcare group in China, and Reed Exhibitions - the world's leading event organizer.
Reed Sinopharm runs a portfolio of 22 highly recognized events, which serve the entire value chain of human health with an extensive market reach to life health sectors.
Each year, Reed Sinopharm plays host to nearly 18,000 local and global exhibitors from over 100 countries and regions at its international trade shows, combined with more than 400 theme conferences and academic seminars. Through these events, Reed Sinopharm offers its customers innovative solutions in improving productivity and tapping potential in the markets. Since 2015, Reed Sinopharm events have covered a total exhibition space of 900,000 sqm and welcomed over 530,000 trade visitors worldwide.
Reed Sinopharm is driven by an aim to serve the industry as a whole, while stimulating mutual development. With the pursuit of excellence and innovation as its ultimate goal, it continues to demonstrate solid actions to support sustainable growth of the entire health sector.